182 related articles for article (PubMed ID: 17695442)
1. Quantification of plasma cell-free DNA in patients with gastric cancer.
Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
[TBL] [Abstract][Full Text] [Related]
2. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.
Tomita H; Ichikawa D; Ikoma D; Sai S; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Otsuji E
Anticancer Res; 2007; 27(4C):2737-41. PubMed ID: 17695440
[TBL] [Abstract][Full Text] [Related]
3. [Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal and gastric cancer].
Tomita H; Ichikawa D; Sai S; Morimura R; Murayama Y; Komatsu S; Ikoma D; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Kokuba Y; Sakakura C; Sonoyama T; Hagiwara A; Otsuji E
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1908-10. PubMed ID: 18219849
[TBL] [Abstract][Full Text] [Related]
4. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
5. Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.
Tani N; Ichikawa D; Ikoma D; Tomita H; Sai S; Ikoma H; Okamoto K; Ochiai T; Ueda Y; Otsuji E; Yamagishi H; Miura N; Shiota G
Anticancer Res; 2007; 27(2):1207-12. PubMed ID: 17465264
[TBL] [Abstract][Full Text] [Related]
6. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
[TBL] [Abstract][Full Text] [Related]
7. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer.
Ichikawa D; Koike H; Ikoma H; Ikoma D; Tani N; Otsuji E; Kitamura K; Yamagishi H
Anticancer Res; 2004; 24(4):2477-81. PubMed ID: 15330201
[TBL] [Abstract][Full Text] [Related]
8. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
[TBL] [Abstract][Full Text] [Related]
9. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
10. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
12. Free circulating DNA as possible tumour marker in colorectal cancer.
Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
[TBL] [Abstract][Full Text] [Related]
13. Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays.
Sozzi G; Roz L; Conte D; Mariani L; Andriani F; Verderio P; Pastorino U
J Natl Cancer Inst; 2005 Dec; 97(24):1848-50. PubMed ID: 16368947
[TBL] [Abstract][Full Text] [Related]
14. DNA integrity in plasma and serum of patients with malignant and benign diseases.
Holdenrieder S; Burges A; Reich O; Spelsberg FW; Stieber P
Ann N Y Acad Sci; 2008 Aug; 1137():162-70. PubMed ID: 18837942
[TBL] [Abstract][Full Text] [Related]
15. Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy.
Cheng C; Omura-Minamisawa M; Kang Y; Hara T; Koike I; Inoue T
Cancer Sci; 2009 Feb; 100(2):303-9. PubMed ID: 19200259
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer.
Ikoma H; Ichikawa D; Daito I; Nobuyuki T; Koike H; Okamoto K; Ochiai T; Ueda Y; Yamagishi H; Otsuji E
Hepatogastroenterology; 2007; 54(75):946-50. PubMed ID: 17591100
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients.
Zheng Y; Cui L; Sun W; Zhou H; Yuan X; Huo M; Chen J; Lou Y; Guo J
Cancer Biomark; 2011-2012; 10(2):71-7. PubMed ID: 22430134
[TBL] [Abstract][Full Text] [Related]
18. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.
Altimari A; Grigioni AD; Benedettini E; Gabusi E; Schiavina R; Martinelli A; Morselli-Labate AM; Martorana G; Grigioni WF; Fiorentino M
Am J Clin Pathol; 2008 May; 129(5):756-62. PubMed ID: 18426736
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer.
Yang Q; Gao J; Xu L; Zeng Z; Sung JJ; Yu J
Biomarkers; 2013 Dec; 18(8):721-5. PubMed ID: 24191714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]